Progress of U34 planning phase is reviewed favorably
An External Evaluation Committee convened by NIDDK reviews the progress of the U34 planning phase. The Committee concludes that the D2d team has made excellent progress in designing the D2d study and in preparing for the clinical trial phase. The Committee recommends that the D2d team proceeds with submitting a U01 grant application. NIDDK concurs with the External Evaluation Committee and invites the D2d team to submit the U01 grant application.